Johnson & Johnson Ups Forecast, Beats On EPS—But Wall Street Is Cautious

Shares of Johnson & Johnson (NYSE:JNJ) are under pressure Thursday, despite a strong second-quarter earnings report.

Here are some key analyst takeaways.

BofA Securities analyst Tim Anderson reiterated a Neutral rating, while raising the price target from $161 to $175.

Guggenheim Securities analyst Vamil Divan maintained a Neutral rating, while lifting the price target from $164 to $167.

RBC Capital Markets analyst Shagun Singh reaffirmed an Outperform rating, while raising the price target from $181 to $185.

Check out other analyst stock ratings.

BofA Securities: Johnson & Johnson earnings came in 3% higher than consensus. The company's operating leverage was "slightly diluted by higher tax," Anderson said in a note.

The company delivered a strong quarter and raised ...